Auxo Firm Directory · Independent Research Profile

Creador

Creador invests in growth companies in India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam. Its public materials describe thematic investing, local-market insight, strategic and operational support, regional expansion, mergers and acquisitions, and value creation.

Key takeaway

Creador publicly describes a regional growth-equity strategy with minority and majority investment flexibility.

Its disclosed activity spans retail, consumer, healthcare, and business and financial services, while its public strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.[1][2][8][12]

What does Creador invest in?

Creador is a private equity firm established in 2011 and focused on investing in growth companies in South and Southeast Asia. It publicly describes support for portfolio-company growth through strategic initiatives that help companies innovate, expand, and lead in their markets.

Creador’s official 2025 announcement states that it has raised over USD3.0 billion across six funds and invested in over 60 companies.[1][2]

Creador states that it uses thematic investing and proactively sources companies with substantial growth potential and resilience. Its approach also emphasizes local-market insight and rigorous analysis.

The firm states that it provides patient capital and is comfortable taking either minority or majority positions.[1]

Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.

Public size / criteria information
Creador’s official 2025 announcement states that it has raised over USD3.0 billion across six funds and invested in over 60 companies. Its stated criteria emphasize growth companies, thematic opportunities with substantial growth potential and resilience, and medium- to long-term value creation. The cited official strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.[2]

What should a business owner evaluate before considering a transaction with Creador?

Owners evaluating Creador can clarify whether the proposed investment would be a minority or majority position and how the firm’s stated strategic and operational support would apply to the company. Public examples indicate work involving mergers and acquisitions, operational efficiency, regional expansion, supplier introductions, and access to capital. The proposed governance structure, follow-on capital expectations, value-creation plan, exit objectives, relevant fund capacity, and transaction terms should be established for the specific opportunity.[1][4][5][6][7]

01

What ownership position and governance rights would Creador seek for this transaction

Creador states that it is comfortable taking either minority or majority positions, so the proposed ownership structure and related governance rights should be clarified for the specific opportunity.[1]
02

Which fund would invest, and what investment-size parameters apply to that fund

Creador states that it has raised over USD3.0 billion across six funds, while the cited official strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.[1][2]
03

What strategic, operational, M&A, and regional-expansion resources would be dedicated to the company

Creador publicly describes strategic and operational support, and its portfolio materials document work involving acquisitions, operational efficiency, supplier introductions, and business expansion.[1][4][5][6][7]

What companies does Creador target?

The publicly stated criteria center on growth companies and thematic opportunities with substantial growth potential and resilience. Creador describes using local-market insight and rigorous analysis in sourcing and evaluating opportunities.

The cited official strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.[1]

Creador’s official 2025 announcement describes deployment across the retail, consumer, healthcare, and business and financial services sectors.[3]

Creador states that it invests in India, Indonesia, Malaysia, the Philippines, Singapore, Thailand, and Vietnam.[1]

Public examples show both direct company investments and support for expansion through acquisitions. Creador identifies CTOS as a majority investment made through Fund II and states that its teams led acquisitions including Juris Technologies, BOL Thailand, RAM Holdings, and Finscore. Its BIG Caring Group portfolio page describes value-creation work focused primarily on mergers and acquisitions, including the merger with Caring Pharmacy.

These examples establish Creador’s involvement in platform growth and acquisition-led expansion, but the sources cited for this profile do not establish a universal platform-versus-add-on policy.[4][7]

Public portfolio examples include CTOS, DALI, Sapphire Foods, and BIG Caring Group. Creador states that it supported DALI through private-label development, supplier introductions, and Asian Development Bank co-investment. Its Sapphire Foods page describes operational efficiency and strategic advice involving ESOP structuring, product launches, meal plans, new categories, and acquisition opportunities.[4][5][6][7]

In April 2025, Creador announced the acquisition of a 13% stake in FPT Long Chau Investment JSC in Vietnam; the announcement described it as Creador’s 59th investment.

Creador led an USD11 million pre-Series A round for UnoAsia, the operator of Uno Digital Bank, and had previously contributed USD21 million to UnoAsia’s pre-seed and seed funding. Creador also invested PHP4 billion, described as USD71.3 million, in Asialink Finance Corporation for an 18% stake and a seat on its board.

The official DALI portfolio page states that Creador first invested in DALI in September 2022 and subsequently supported its growth through private-label development, supplier introductions, and Asian Development Bank co-investment.[5][8][9][10]

What is not clear from Creador's public investment criteria?

The official Long Chau transaction announcement does not disclose the consideration paid for the 13% stake.

The cited official strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.

The cited official terms page identifies website governing law and website-use conditions but does not identify a fund-level regulatory registration, securities license, or investment-adviser status for Creador.[1][8][12]

Questions to ask when evaluating Creador as a buyer or investment partner

What ownership position and governance rights would Creador seek for this transaction?
Creador states that it is comfortable taking either minority or majority positions, so the proposed ownership structure and related governance rights should be clarified for the specific opportunity.[1]
Which fund would invest, and what investment-size parameters apply to that fund?
Creador states that it has raised over USD3.0 billion across six funds, while the cited official strategy page does not state a universal minimum investment size, maximum investment size, or fund-by-fund check-size range.[1][2]
What strategic, operational, M&A, and regional-expansion resources would be dedicated to the company?
Creador publicly describes strategic and operational support, and its portfolio materials document work involving acquisitions, operational efficiency, supplier introductions, and business expansion.[1][4][5][6][7]
What is the expected investment horizon and exit approach for this specific company?
Creador describes patient capital and a medium- to long-term approach.[1]
What transaction fees, expenses, exclusivity terms, indemnities, and closing conditions would apply?
Creador’s investment approach and selected transactions are described publicly; the fees, expenses, exclusivity terms, indemnities, and closing conditions for this opportunity should be confirmed directly.[1][8][9][10]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. Transaction size / criteria
  3. Industry / market focus
  4. Transaction / portfolio evidence
  5. Transaction / portfolio evidence
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. Transaction / portfolio evidence
  10. Transaction / portfolio evidence
  11. Structure / regulatory context
  12. Public disclosure information
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.